MindWalk Holdings (HYFT) EBIT (QoQ) (2021 - 2026)
Powered by 
Analysis
MindWalk Holdings (HYFT) EBIT (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -19.29% |
| Jan 31, 2026 | -32.34% |
| Oct 31, 2025 | 33.91% |
| Jul 31, 2025 | 75.47% |
| Apr 30, 2025 | 29.53% |
| Jan 31, 2025 | -489.87% |
| Oct 31, 2024 | 99.92% |
| Jul 31, 2024 | -21,514.77% |
| Apr 30, 2024 | -566.54% |
| Jan 31, 2024 | 99.94% |
| Oct 31, 2023 | 16.95% |
| Jul 31, 2023 | -114,040.95% |
| Apr 30, 2023 | -32.24% |
| Jan 31, 2023 | 42.36% |
| Oct 31, 2022 | 24.57% |
| Jul 31, 2022 | -130.72% |
| Apr 30, 2022 | -28.65% |
| Jan 31, 2022 | 26.07% |
| Oct 31, 2021 | -26.14% |
| Jul 31, 2021 | -14.58% |